Muscle Weakness Terminated Phase 2 Trials for Amifampridine (DB11640)

Also known as: Weakness, Muscle / Muscle Weakness | Patient / Muscle Weakness / Patient / Motor weakness / Paresis / Weakness muscle / Muscular weakness / Muscle weakness NOS

IndicationStatusPhase
DBCOND0002242 (Muscle Weakness)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02090725Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)Treatment